Search

alt
0500

FiltersClear filters

Status
Sex
Age

Pfizer clinical trials

Search Results

We found 5 clinical trials for: Prostate cancer, 150 miles

3 trials recruiting
MEVPRO Prostate Cancer Clinical Trials
Clinical trials exploring mevrometostat as a potential treatment for metastatic prostate cancer.
  • Prostate cancer
  • Recruiting
View studies
Recruiting
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
  • Prostate cancer
  • Recruiting
NCT06629779
Sex: Male
Age: 18+
Locations: 97
View study
Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
  • Prostate cancer
  • Recruiting
NCT07028853
Sex: Male
Age: 18+
Locations: 302
View study
Recruiting
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
  • Prostate cancer
  • Recruiting
NCT03460977
Sex: All
Age: 18+
Locations: 82
View study
Recruiting
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
  • Prostate cancer
  • Recruiting
NCT04606446
Sex: All
Age: 18+
Locations: 44
View study
Aug 01, 2026 - Planned start date (Not yet recruiting)
A Study of Mevrometostat With Enzalutamide in People With Prostate Cancer Who Have Previously Received Androgen Receptor Pathway Inhibitor Therapy
  • Prostate cancer
  • Not yet recruiting
NCT07592910
Sex: Male
Age: 18+
Locations: 0
View study